Avestar Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,287
| Closed | -$349K | – | 422 |
|
2024
Q1 | $349K | Sell |
1,287
-44
| -3% | -$11.9K | 0.04% | 281 |
|
2023
Q4 | $315K | Sell |
1,331
-119
| -8% | -$28.1K | 0.04% | 265 |
|
2023
Q3 | $284K | Buy |
1,450
+17
| +1% | +$3.33K | 0.04% | 244 |
|
2023
Q2 | $301K | Buy |
+1,433
| New | +$301K | 0.05% | 213 |
|